The Pharmacological Activity of Topolins and Their Ribosides
Publisher
Springer Singapore
Reference55 articles.
1. Amiable C, Pochet S, Padilla A et al (2013) N6-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1. PLoS One 8:e80755. https://doi.org/10.1371/journal.pone.0080755
2. Béres T, Zatloukal M, Voller J et al (2010) Tandem mass spectrometry identification and LC-MS quantification of intact cytokinin nucleotides in K-562 human leukemia cells. Anal Bioanal Chem 398:2071–2080. https://doi.org/10.1007/s00216-010-4126-5
3. Bifulco M, D’Alessandro A, Paladino S et al (2013) N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. FEBS J 280:6223–6232. https://doi.org/10.1111/febs.12544
4. Bowie LE, Maiuri T, Alpaugh M et al (2018) N6-furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylation. Proc Natl Acad Sci 115:E7081–E7090. https://doi.org/10.1073/pnas.1801772115
5. Brizzolari A, Marinello C, Carini M et al (2016) Evaluation of the antioxidant activity and capacity of some natural N6-substituted adenine derivatives (cytokinins) by fluorimetric and spectrophotometric assays. J Chromatogr B Anal Technol Biomed Life Sci 1019:164–168. https://doi.org/10.1016/j.jchromb.2015.12.047